AL
MS icon

Aspiriant LLC’s Morgan Stanley MS Stock Holding History

Aspiriant LLC’s Portfolio MS Stock Details MS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Buy
3,900
+401
+11% +$79.4K 0.02% 190
2026
Q1 		$576K Sell
3,499
-50
-1% -$8.66K 0.02% 202
2025
Q4 		$630K Buy
3,549
+404
+13% +$67.4K 0.02% 197
2025
Q3 		$500K Sell
3,145
-66
-2% -$9.75K 0.02% 198
2025
Q2 		$452K Sell
3,211
-155
-5% -$19K 0.01% 209
2025
Q1 		$393K Buy
3,366
+405
+14% +$52.2K 0.01% 208
2024
Q4 		$372K Buy
2,961
+173
+6% +$21.3K 0.01% 218
2024
Q3 		$291K Sell
2,788
-246
-8% -$24.8K 0.01% 238
2024
Q2 		$295K Sell
3,034
-1,297
-30% -$123K 0.01% 233
2024
Q1 		$408K Buy
4,331
+56
+1% +$4.93K 0.02% 216
2023
Q4 		$399K Buy
4,275
+151
+4% +$12.1K 0.02% 211
2023
Q3 		$337K Buy
4,124
+880
+27% +$76.4K 0.02% 211
2023
Q2 		$277K Sell
3,244
-65
-2% -$5.56K 0.01% 234
2023
Q1 		$291K Sell
3,309
-6
-0.2% -$560 0.02% 222
2022
Q4 		$282K Buy
3,315
+369
+13% +$31.4K 0.01% 221
2022
Q3 		$232K Buy
2,946
+184
+7% +$15.5K 0.01% 237
2022
Q2 		$209K Sell
2,762
-99
-3% -$8.11K 0.01% 263
2022
Q1 		$250K Buy
+2,861
New +$276K 0.01% 242
2019
Q1 		– Sell
-6,486
Closed -$257K – 239
2018
Q4 		$257K Buy
6,486
+264
+4% +$11.5K 0.02% 199
2018
Q3 		$290K Sell
6,222
-475
-7% -$23.2K 0.02% 197
2018
Q2 		$317K Sell
6,697
-521
-7% -$27.2K 0.03% 197
2018
Q1 		$389K Buy
+7,218
New +$400K 0.03% 165
2014
Q2 		– Sell
-8,100
Closed -$252K – 82
2014
Q1 		$252K Sell
8,100
-3,826
-32% -$118K 0.04% 75
2013
Q4 		$374K Buy
+11,926
New +$355K 0.06% 61

Other funds holding MS

Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $78.8B AUM 48.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aspiriant LLC's MS Position: Q2 2026 in Review

Aspiriant LLC increased its Morgan Stanley (MS) stake by 11% in Q2 2026, buying an estimated $79.4K and bringing the position to 3,900 shares worth $815K. The position accounts for 0.02% of the portfolio, ranked #190.

Aspiriant LLC first reported a position in MS in Q4 2013 and has held it in 24 quarters since. 2,733 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Aspiriant LLC held 3,900 shares of Morgan Stanley worth $815K as of Q2 2026.
  • Aspiriant LLC bought 401 Morgan Stanley shares in Q2 2026, an estimated $79.4K.
  • Morgan Stanley made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #190 holding.
  • Aspiriant LLC first reported a position in Morgan Stanley in Q4 2013 and has held it in 24 quarters since.
  • 2,733 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.